INNT
TOTAL INVALIDATION PROCESSED BY THE IB
11/07/2025
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Titulares
Representantes
Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C.
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders; medical preparations for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders; and veterinary preparations for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders; sanitary preparations for medical purposes; dietetic food for treating viral and infectious diseases, for treating cancer, for treating immune system related diseases and disorders, for the prevention and treatment of cancer, and substances in the nature of beverages for medical or veterinary use; monoclonal antibodies and antibody mixtures for medical use, namely, diagnostic kits consisting primarily of monoclonal antibodies for use in disease testing; monoclonal antibodies for immunomodulatory treatments, in particular for the treatment of diseases mediated by the differentiation cluster 26 molecule CD26; pharmaceutical preparations comprising as active ingredient monoclonal antibodies having immunomodulatory effects, in particular for the treatment of diseases mediated by the 26 differentiation cluster molecule CD26; dietetic foods, namely, yogurt and rice-derived products, namely, rice flour adapted for medical use, dietetic beverages adapted for medical use, food supplements, enzyme food supplements, protein food supplements, protein supplements for animals, by-products of the processing of cereals for dietetic or medical use, biological preparations for medical use, biological preparations for veterinary use, pills for medicines, namely, immunosuppressant pills, chemical preparations for medical use, namely, for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders, chemical preparations for veterinary use, namely, for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders, biological tissue cultures for medical use, biological tissue cultures for veterinary use, enzyme preparations for medical use, enzyme preparations for veterinary use, enzymes for medical use, enzymes for veterinary use, medicines for veterinary use for the treatment of viral and infectious diseases, for the treatment of cancer, for the treatment of immune system related diseases and disorders, for the prevention and treatment of cancer, remedies for veterinary use, namely, monoclonal antibodies for immunomodulatory treatments, vaccines, veterinary products in the nature of anti-infective products for veterinary use; living tissue grafts, surgical implants composed of living tissue, radiological contrast substances for medical use, diagnostic preparations for medical use, biomarker reagents for diagnosis for medical use, adjuvants for medical use, chemical preparations for pharmaceutical use, drugs for medical use, namely, for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders, pharmaceutical preparations, namely, elixirs for treating viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders, plant extracts for pharmaceutical use, medicinal infusions for treating viral and infectious diseases, for treating cancer, for treating immune system related diseases and disorders, for the prevention and treatment of cancer, lotions for pharmaceutical use, medicines or human medicine for the treatment of viral and infectious diseases, for the treatment of cancer, for the treatment of immune system related diseases and disorders, for the prevention and treatment of cancer, remedies for human medicine in the nature of solution for injection for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders, pharmaceutical preparations for skin care, pharmaceutical preparations for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders, syrups for pharmaceutical use for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders
Classe 10
Surgical, medical, dental and veterinary apparatus and instruments, namely, infusion bag, vial, syringe; needles for medical use, medical apparatus and instruments, containers for applying medicines, namely, infusion bag, vial, syringe, hypodermic syringes, syringes for medical use, pumps for medical use, namely, infusion pump
Histórico de despachos e eventos da marca no USPTO.
34 publicações encontradas
TOTAL INVALIDATION PROCESSED BY THE IB
11/07/2025
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
24/06/2025
INVALIDATION PROCESSED
24/06/2025
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
26/03/2025
CANCELLED SECTION 71
26/07/2024
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
09/01/2023
NEW REPRESENTATIVE AT IB RECEIVED
31/12/2021
FINAL DECISION TRANSACTION PROCESSED BY IB
01/06/2018
FINAL DISPOSITION NOTICE SENT TO IB
16/04/2018
FINAL DISPOSITION PROCESSED
16/04/2018
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/04/2018
REGISTERED-PRINCIPAL REGISTER
09/01/2018
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24/10/2017
PUBLISHED FOR OPPOSITION
24/10/2017
NOTIFICATION PROCESSED BY IB
21/10/2017
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/10/2017
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/10/2017
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/10/2017
APPROVED FOR PUB - PRINCIPAL REGISTER
19/09/2017
TEAS/EMAIL CORRESPONDENCE ENTERED
29/08/2017
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/08/2017
ASSIGNED TO LIE
23/08/2017
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/08/2017
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
24/07/2017
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
24/07/2017
REFUSAL PROCESSED BY IB
18/03/2017
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
28/02/2017
REFUSAL PROCESSED BY MPU
28/02/2017
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
25/02/2017
NON-FINAL ACTION WRITTEN
24/02/2017
APPLICATION FILING RECEIPT MAILED
21/02/2017
ASSIGNED TO EXAMINER
17/02/2017
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
17/02/2017
SN ASSIGNED FOR SECT 66A APPL FROM IB
16/02/2017
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.